Myriad Genetics

+$0.38 (+1.22%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYGN and other ETFs, options, and stocks.

About MYGN

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through the Diagnostics and Other segments.

CEO
Paul J. Diaz
Employees
2,700
Headquarters
Salt Lake City, Utah
Founded
1991

MYGN Key Statistics

Market Cap
2.44B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
412.41K
High Today
$32.45
Low Today
$31.16
Open Price
$31.16
Volume
428.23K
52 Week High
$34.02
52 Week Low
$11.71

MYGN Earnings

-$0.47
-$0.21
$0.05
$0.31
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours
Preview Earnings Call
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure